In a move that has left tennis fans both concerned and curious, Alexander Zverev has withdrawn from the ABN AMRO Open in Rotterdam, citing ongoing ankle issues. But here's where it gets controversial: is this a wise decision to prioritize long-term health, or could it be seen as a missed opportunity to compete in a tournament he holds dear? Let’s dive into the details.
Alexander Zverev, the 24-time tour-level titlist and one of Germany’s most prominent tennis stars, announced his withdrawal from the Rotterdam tournament on Wednesday, February 4, 2026. The 28-year-old, who last competed in Rotterdam in 2023, expressed his disappointment in a statement. “I find it incredibly unfortunate that I have to make this decision,” Zverev said. “The ABN AMRO Open gave me a chance as a young player, and that’s why I always enjoy returning. However, given my history with my ankle, I have to prioritize my recovery and can’t take any risks. I wish everyone in Rotterdam a wonderful week.”
Zverev’s decision comes on the heels of a strong start to his 2026 season, which included a semifinal appearance at the Australian Open, where he lost a grueling five-set match to Carlos Alcaraz. According to the Infosys ATP Win/Loss Index, he holds a 6-2 record this year, showcasing his competitive form. Yet, recurring ankle problems have forced him to step back, with his physio advising a thorough recovery before returning to the court.
And this is the part most people miss: Zverev’s ankle injury history is no small matter. Tournament director Richard Krajicek acknowledged the situation, saying, “Given his history, we would naturally have liked to see Alexander back on court, but we also understand his decision here. Everyone still remembers the images and the impact of his previous ankle injury.” This raises a thought-provoking question: In a sport as physically demanding as tennis, how should players balance the desire to compete with the need to safeguard their long-term health?
Zverev’s absence from Rotterdam will undoubtedly be felt, especially considering his six previous appearances at the tournament. In 2023, he fell to Tallon Griekspoor in the second round, but his connection to the event remains strong. Meanwhile, the ABN AMRO Open, running from February 9-16, still boasts a star-studded field, including Top 10 players like Alex de Minaur, Felix Auger-Aliassime, and Alexander Bublik.
Here’s a bold interpretation: While Zverev’s withdrawal is a setback for the tournament, it could also be seen as a strategic move to ensure he’s in peak condition for future Grand Slams. But is this the right call, or is he missing out on valuable match practice? We’d love to hear your thoughts in the comments.
As we wish Zverev a smooth recovery, one thing is clear: his decision highlights the delicate balance between ambition and caution in professional tennis. What do you think? Is Zverev making the right choice, or should he have pushed through? Let the debate begin!
